Publication | Closed Access

Single Intranasal Administration of 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine in C57BL/6 Mice Models Early Preclinical Phase of Parkinson’s Disease

Neurodegenerative DiseasesMedicineParkinson ’NeuropharmacologySingle Intranasal AdministrationNeuroscienceNeurologyDopaminePharmacologyNeurochemistry